BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 30706542)

  • 1. Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis.
    Traub J; Traffehn S; Ochs J; Häusser-Kinzel S; Stephan S; Scannevin R; Brück W; Metz I; Weber MS
    Brain Pathol; 2019 Sep; 29(5):640-657. PubMed ID: 30706542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment.
    Cunill V; Massot M; Clemente A; Calles C; Andreu V; Núñez V; López-Gómez A; Díaz RM; Jiménez MLR; Pons J; Vives-Bauzà C; Ferrer JM
    Front Immunol; 2018; 9():1097. PubMed ID: 29896193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.
    Longbrake EE; Ramsbottom MJ; Cantoni C; Ghezzi L; Cross AH; Piccio L
    Mult Scler; 2016 Jul; 22(8):1061-1070. PubMed ID: 26459150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.
    Fleischer V; Friedrich M; Rezk A; Bühler U; Witsch E; Uphaus T; Bittner S; Groppa S; Tackenberg B; Bar-Or A; Zipp F; Luessi F
    Mult Scler; 2018 Apr; 24(5):632-641. PubMed ID: 28436295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients.
    Montes Diaz G; Fraussen J; Van Wijmeersch B; Hupperts R; Somers V
    Sci Rep; 2018 May; 8(1):8194. PubMed ID: 29844361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies.
    Montes Diaz G; Hupperts R; Fraussen J; Somers V
    Autoimmun Rev; 2018 Dec; 17(12):1240-1250. PubMed ID: 30316988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimethyl fumarate modulates the regulatory T cell response in the mesenteric lymph nodes of mice with experimental autoimmune encephalomyelitis.
    Lima ADR; Ferrari BB; Pradella F; Carvalho RM; Rivero SLS; Quintiliano RPS; Souza MA; Brunetti NS; Marques AM; Santos IP; Farias AS; Oliveira EC; Santos LMB
    Front Immunol; 2024; 15():1391949. PubMed ID: 38765015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimethyl fumarate therapy suppresses B cell responses and follicular helper T cells in relapsing-remitting multiple sclerosis.
    Holm Hansen R; Højsgaard Chow H; Sellebjerg F; Rode von Essen M
    Mult Scler; 2019 Aug; 25(9):1289-1297. PubMed ID: 30043661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.
    Li R; Rezk A; Ghadiri M; Luessi F; Zipp F; Li H; Giacomini PS; Antel J; Bar-Or A
    J Immunol; 2017 Jan; 198(2):691-698. PubMed ID: 27974457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17
    Lückel C; Picard F; Raifer H; Campos Carrascosa L; Guralnik A; Zhang Y; Klein M; Bittner S; Steffen F; Moos S; Marini F; Gloury R; Kurschus FC; Chao YY; Bertrams W; Sexl V; Schmeck B; Bonetti L; Grusdat M; Lohoff M; Zielinski CE; Zipp F; Kallies A; Brenner D; Berger M; Bopp T; Tackenberg B; Huber M
    Nat Commun; 2019 Dec; 10(1):5722. PubMed ID: 31844089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis.
    Bevilacqua Rolfsen Ferreira da Silva G; Pereira das Neves S; Roque Oliveira SC; Marques F; Gomes de Oliveira A; de Lima Leite F; Cerqueira JJ
    J Autoimmun; 2022 Oct; 132():102893. PubMed ID: 36029715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count.
    Longbrake EE; Cantoni C; Chahin S; Cignarella F; Cross AH; Piccio L
    Mult Scler; 2018 May; 24(6):728-738. PubMed ID: 28480794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis.
    Diebold M; Sievers C; Bantug G; Sanderson N; Kappos L; Kuhle J; Lindberg RLP; Derfuss T
    J Autoimmun; 2018 Jan; 86():39-50. PubMed ID: 28958667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.
    Wu Q; Wang Q; Mao G; Dowling CA; Lundy SK; Mao-Draayer Y
    J Immunol; 2017 Apr; 198(8):3069-3080. PubMed ID: 28258191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile.
    Medina S; Villarrubia N; Sainz de la Maza S; Lifante J; Costa-Frossard L; Roldán E; Picón C; Álvarez-Cermeño JC; Villar LM
    Mult Scler; 2018 Sep; 24(10):1317-1327. PubMed ID: 28653862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate.
    Nicholas JA; Boster AL; Imitola J; O'Connell C; Racke MK
    Drug Des Devel Ther; 2014; 8():897-908. PubMed ID: 25045248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalation of dimethyl fumarate-encapsulated solid lipid nanoparticles attenuate clinical signs of experimental autoimmune encephalomyelitis and pulmonary inflammatory dysfunction in mice.
    Pinto BF; Ribeiro LNB; da Silva GBRF; Freitas CS; Kraemer L; Oliveira FMS; Clímaco MC; Mourão FAG; Santos GSPD; Béla SR; Gurgel ILDS; Leite FL; de Oliveira AG; Vilela MRSDP; Oliveira-Lima OC; Soriani FM; Fujiwara RT; Birbrair A; Russo RC; Carvalho-Tavares J
    Clin Sci (Lond); 2022 Jan; 136(1):81-101. PubMed ID: 34904644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimethyl fumarate downregulates the immune response through the HCA
    von Glehn F; Dias-Carneiro RPC; Moraes AS; Farias AS; Silva VAPG; Oliveira FTM; Silva CEBG; de Carvalho F; Rahal E; Baecher-Allan C; Santos LMB
    Mult Scler Relat Disord; 2018 Jul; 23():46-50. PubMed ID: 29763776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study.
    Marastoni D; Buriani A; Pisani AI; Crescenzo F; Zuco C; Fortinguerra S; Sorrenti V; Marenda B; Romualdi C; Magliozzi R; Monaco S; Calabrese M
    Front Immunol; 2019; 10():1666. PubMed ID: 31379857
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunomodulation by dimethyl fumarate treatment improves mouse sciatic nerve regeneration.
    Bombeiro AL; Pereira BTN; Bonfanti AP; Oliveira ALR
    Brain Res Bull; 2020 Jul; 160():24-32. PubMed ID: 32305403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.